|
Platelet function inhibitors
Citations 161-170 of 251 total displayed.
|
Past content
(since Oct 2000):
|
- Clinical Investigations and Reports
Cerebral Microembolism Is Blocked by Tirofiban, a Selective Nonpeptide Platelet Glycoprotein IIb/IIIa Receptor Antagonist
- Ulrich Junghans and Mario Siebler
Circulation 2003;107:2717-2721; published online before print as doi:10.1161/01.CIR.0000070544.15890.0E
[Abstract]
[Full text]
- Articles
Cerebral Microembolism Is Blocked by Tirofiban, a Selective Nonpeptide Platelet Glycoprotein IIb/IIIa Receptor Antagonist
- Ulrich Junghans and Mario Siebler
Circulation published May 12, 2003, doi:10.1161/01.CIR.0000070544.15890.0E
[Abstract]
- Editorials
Are Antiplatelet Effects of Clopidogrel Inhibited by Atorvastatin?: A Research Question Formulated but Not Yet Adequately Tested
- Victor L. Serebruany, Steven R. Steinhubl, and Charles H. Hennekens
Circulation 2003;107:1568-1569, doi:10.1161/01.CIR.0000065125.50640.70
[Full text]
- Clinical Investigations and Reports
Adjunctive Platelet Glycoprotein IIb/IIIa Receptor Inhibition With Tirofiban Before Primary Angioplasty Improves Angiographic Outcomes: Results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) Pilot Trial
- David P. Lee, Niall A. Herity, Bonnie L. Hiatt, William F. Fearon, Mehrdad Rezaee, Andrew J. Carter, Michelle Huston, Donald Schreiber, Peter M. DiBattiste, and Alan C. Yeung
Circulation 2003;107:1497-1501; published online before print as doi:10.1161/01.CIR.0000056120.00513.7A
[Abstract]
[Full text]
- Special Review
Important Triad in Cardiovascular Medicine: Diabetes, Coronary Intervention, and Platelet Glycoprotein IIb/IIIa Receptor Blockade
- A. Michael Lincoff
Circulation 2003;107:1556-1559, doi:10.1161/01.CIR.0000055653.52489.E9
[Full text]
- Articles
Adjunctive Platelet Glycoprotein IIb/IIIa Receptor Inhibition With Tirofiban Before Primary Angioplasty Improves Angiographic Outcomes. Results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) Pilot Trial
- David P. Lee, Niall A. Herity, Bonnie L. Hiatt, William F. Fearon, Mehrdad Rezaee, Andrew J. Carter, Michelle Huston, Donald Schreiber, Peter M. DiBattiste, and Alan C. Yeung
Circulation published March 10, 2003, doi:10.1161/01.CIR.0000056120.00513.7A
[Abstract]
- Clinical Investigations and Reports
Inhibitory Effects of Glycoprotein IIb/IIIa Antagonists and Aspirin on the Release of Soluble CD40 Ligand During Platelet Stimulation
- Lisa Nannizzi-Alaimo, Veronica L. Alves, and David R. Phillips
Circulation 2003;107:1123-1128; published online before print as doi:10.1161/01.CIR.0000053559.46158.AD
[Abstract]
[Full text]
- Clinical Investigations and Reports
Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes
- Salim Yusuf, Shamir R. Mehta, Feng Zhao, Bernard J. Gersh, Patrick J. Commerford, Mel Blumenthal, Andrzej Budaj, Thomas Wittlinger, Keith A.A. Fox on Behalf of the CURE (Clopidogrel in Unstable angina to prevent Recurrent Events) Trial Investigators*
Circulation 2003;107:966-972; published online before print as doi:10.1161/01.CIR.0000051362.96946.15
[Abstract]
[Full text]
- Articles
Inhibitory Effects of Glycoprotein IIb/IIIa Antagonists and Aspirin on the Release of Soluble CD40 Ligand During Platelet Stimulation
- Lisa Nannizzi-Alaimo, Veronica L. Alves, and David R. Phillips
Circulation published February 17, 2003, doi:10.1161/01.CIR.0000053559.46158.AD
[Abstract]
- Articles
Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes
- Salim Yusuf, Shamir R. Mehta, Feng Zhao, Bernard J. Gersh, Patrick J. Commerford, Mel Blumenthal, Andrzej Budaj, Thomas Wittlinger, Keith A.A. Fox on Behalf of the CURE (Clopidogrel in Unstable angina to prevent Recurrent Events) Trial Investigators
Circulation published February 17, 2003, doi:10.1161/01.CIR.0000051362.96946.15
[Abstract]
|
|
